Results 101 to 110 of about 1,949 (177)

Embracing change: impermanence acceptance mediates differences in death processing between long-term ayahuasca users and non-users. [PDF]

Psychopharmacology (Berl)
David J, Berkovich-Ohana A, Dor-Ziderman Y.   +2 more
europepmc   +1 more source

Psychedelics and the Serotonin Hypothesis of Eating Disorders. [PDF]

Brain Sci
Bilenker D, Avena NM.
europepmc   +1 more source

The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews. [PDF]

Brain Sci
Correa da Costa S, Bormann NL, Oesterle T, McGinnis MT, Ho MF, Vettleson-Trutza SA, Rummans T, Gold MS.   +7 more
europepmc   +1 more source

Psychedelics for major depression-From controlled research settings into broader clinical use. [PDF]

Cell Rep Med
Avram M, Borgwardt S.
europepmc   +1 more source

What fMRI studies say about the nature of the psychedelic effect: a scoping review. [PDF]

Front Neurosci
Beneš M, Páleníček T, Horáček J.
europepmc   +1 more source

Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence. [PDF]

Explor Res Clin Soc Pharm
Shiju S, Tirumala R, Marseille E.
europepmc   +1 more source

Inhaled N, N-dimethyltryptamine diminishes connectivity between the ventral tegmental area and the nucleus accumbens: relevance to pathologies of mesolimbic and mesocortical pathways. [PDF]

Sci Rep
Lima G, Soares C, Teixeira M, Pais M, Cabral C, Rijo P, Castelo-Branco M.   +6 more
europepmc   +1 more source

Psychedelic- and Substance-Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access. [PDF]

Brain Behav
Halm S.
europepmc   +1 more source

Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings. [PDF]

Brain Behav
Calnan M, Blest-Hopley G, Busch C, Adams M, Ruffell SGD, Piper T, Roseman L, Kettner H, Carhart-Harris R.   +8 more
europepmc   +1 more source